Changes in gut microbiota influence which patients get AIG-related neuroendocrine tumors
Researchers found how changes in gut microbiota influence stomach health and even the growth of neuroendocrine tumors in autoimmune gastritis patients
2025-10-08
(Press-News.org) Researchers from Osaka Metropolitan University have discovered how the balance of bacteria in the stomach affects the growth of neuroendocrine tumors (NETs). By identifying the specific bacteria involved and the biochemical reactions that cause tumor growth, the researchers hope to create a new diagnostic technique to detect which patients are most likely to develop cancer.
Autoimmune gastritis (AIG) is a long-term condition in which the body’s immune system mistakenly attacks the lining of the stomach. This ongoing immune response gradually damages the stomach, affecting how it functions and its ability to protect itself from harmful agents. Over time, these changes can increase the risk of developing NETs, a type of tumor that develops from hormone-producing cells in the stomach.
The stomach is home to the gastric microbiota, a diverse community of microorganisms that are important for maintaining health. The research group led by Dr. Koji Otani of the Osaka Metropolitan University Graduate School of Medicine analyzed changes in the gastric microbiota and tissue-derived metabolites using DNA extracted from biopsy specimens to understand how these microorganisms are affected in AIG patients. Understanding how this process occurs might help to understand how tumors form in the stomach.
In patients, “α-diversity” is often used to assess gut health, as it reflects the number of different microbial species present in a given sample. High α-diversity is usually a sign of a healthy, well-balanced gut; however, it was found to be reduced in AIG patients.
Intriguingly, distinct bacterial communities were observed depending on whether the patient had developed an NET or not. This was supported by heatmap analysis of the relative abundance of gastric microbiota that revealed distinct compositional patterns in the group that had developed NETs.
In particular, the NET-positive group showed increased levels of Haemophilus parainfluenzae and Fusobacterium species, particularly F. periodonticum and F. nucleatum. While these bacteria are typically found in healthy stomachs, increased levels are often responsible for inflammatory conditions.
In addition, they found decreases in lactic acid bacteria and Streptococcus salivarius that are involved in maintaining health and commonly inhibit harmful bacteria.
The group used metabolomic analysis to investigate the biochemical reactions that were occurring. They found that the cells of AIG patients were changing the way they generate and use energy, a process known as metabolic reprogramming, compared to normal tissue.
This metabolic reprogramming was characterized by decreased activity in the glycolysis and TCA cycle pathways, cycles commonly used to generate energy. Instead, metabolism had shifted towards alternative pathways to meet energy demands. This shift in metabolism can affect cell function, as well as inflammation and tissue remodeling processes.
The researchers concluded that specific tissue metabolic patterns were associated with AIG, and specific gastric microbiota signatures were associated with development of gastric NETs. “The study suggests that in AIG patients, changes in host metabolism occur before alterations in the gastric microbiota, potentially creating a microenvironment that favors the growth of bacteria linked to gastric NET formation,” Dr. Otani explained. “Our findings are expected to enhance understanding of the progression from AIG onset to gastric NET development and support the creation of new diagnostic markers for early detection and prevention.”
The study was published in Journal of Gastroenterology.
###
About OMU
Established in Osaka as one of the largest public universities in Japan, Osaka Metropolitan University is committed to shaping the future of society through the “Convergence of Knowledge” and the promotion of world-class research. For more research news, visit https://www.omu.ac.jp/en/ and follow us on social media: X, Facebook, Instagram, LinkedIn.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-10-08
Bottom Line: Adoption of Medicaid expansion in U.S. states appeared to improve both five-year cause-specific and overall survival in cancer patients.
Journal in Which the Study was Published: Cancer Discovery, a journal of the American Association for Cancer Research (AACR)
Author: Elizabeth Schafer, MPH, associate scientist at the American Cancer Society
Background: In 2014, a provision under the Patient Protection and Affordable Care Act (ACA) went into effect that allowed states to opt into expanding Medicaid eligibility to adults with incomes up to 138% of the federal poverty guidelines. Existing studies have linked Medicaid expansion to increased ...
2025-10-08
CLEVELAND, Ohio (October 8, 2025)—Menopause before the age of 45 (known as early menopause) is associated with an increased risk of an array of serious diseases, including cardiovascular disease and osteoporosis. A new study suggests that it may also force women out of the workforce prematurely, although carefully timed hormone therapy may help women remain employed. Results of the study are published online today in Menopause, the journal of The Menopause Society.
Early menopause, whether natural or surgical ...
2025-10-08
New York — October 7, 2025 — Three of America’s most promising young scientists were awarded top honors tonight at the 2025 Blavatnik National Awards for Young Scientists, one of the country’s most significant prizes for early-career researchers. Presented by the Blavatnik Family Foundation and The New York Academy of Sciences, the awards recognize exceptional scientific achievement and innovation by U.S.-based researchers aged 42 and younger.
This year’s Laureates were selected from a competitive pool of 310 nominees representing 161 academic ...
2025-10-08
Peer reviewed – Experimental study – Human DNA
Scientists at the University of East Anglia and Oxford Biodynamics have developed a high accuracy blood test to diagnose Chronic Fatigue Syndrome, also known as Myalgic Encephalomyelitis (ME/CFS).
The debilitating long-term illness affects millions worldwide - including over 400,000 sufferers in the UK - but is poorly understood and has long lacked reliable diagnostic tools.
With 96 per cent accuracy, the test offers new hope for those living with the condition - which is often ...
2025-10-07
Calorie labelling, which became law in April 2022 in England, is associated with only a small (2%) average reduction in the energy content of food that is available away from home, finds research published in the open access journal BMJ Public Health.
And these changes are primarily due to swapping in slightly lower calorie items, rather than reformulating existing ones, with no changes observed in continuously available items. The impact on population health is likely to be “moderate to limited,” conclude the researchers.
Eating at restaurants, fast food outlets, and ordering takeaways, collectively known as out-of-home food outlets, is common and associated with ...
2025-10-07
The strong opioid painkiller, tramadol, is not that effective at easing chronic pain for which it’s widely prescribed, finds a pooled data analysis of the available research, published online in BMJ Evidence Based Medicine.
And it likely increases the risk of serious side effects, including heart disease, the findings indicate, prompting the researchers to conclude that the potential harms of tramadol probably outweigh its benefits, and that its use should be minimised.
Tramadol is a dual action opioid widely prescribed for the treatment of moderate ...
2025-10-07
Exercise snacks—intentional short bursts of physical activity—may be an effective way of boosting the cardiorespiratory fitness of physically inactive adults, finds a synthesis of the available research, published online in the British Journal of Sports Medicine.
Adherence to exercise snacking throughout the day was high, the findings indicate, and this approach could counter perceived lack of time and low motivation—frequently cited barriers to fulfilling the recommended weekly quota of physical activity for health—say the researchers.
Globally, ...
2025-10-07
Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either guide immediate treatment or help match patients to clinical trials for over 15,000 women a year, say scientists at the University of Cambridge.
In 2022, 2.3 million women were diagnosed with breast cancer worldwide and there were 670,000 related deaths. Despite significant progress in recent years, it remains challenging to accurately identify the best treatments for individual patients and to predict cases with poorer prognosis.
Whole genome sequencing ...
2025-10-07
Women who have Caesarean births at an advanced stage of labour are about eight times more likely to develop scars in the womb which are known to increase the likelihood of premature births in future pregnancies, UCL researchers have found.
The study, published in the American Journal of Obstetrics & Gynecology, looked at how the stage of labour when the operation is performed affects where the scar forms and how well it heals. More than 40 per cent of all births in high-income countries including England are now by Caesarean.
As labour progresses, ...
2025-10-07
(Barcelona, Spain, Wednesday 8 September 2025) The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM'25) has revealed.1
GLP-1 receptor agonists are now widely prescribed for individuals with type 2 diabetes and weight loss, with a 700% increase in usage reported in the United States between 2019 and 2023.² These medications alter glucose metabolism, gastric motility and sympathetic tone, which may lead to unique uptake patterns on PET-CT. Previous case reports have shown increased FDG uptake in skeletal ...
LAST 30 PRESS RELEASES:
[Press-News.org] Changes in gut microbiota influence which patients get AIG-related neuroendocrine tumors
Researchers found how changes in gut microbiota influence stomach health and even the growth of neuroendocrine tumors in autoimmune gastritis patients
